1.23
price down icon6.82%   -0.09
after-market Handel nachbörslich: 1.24 0.01 +0.81%
loading

Pliant Therapeutics Inc Aktie (PLRX) Neueste Nachrichten

pulisher
Dec 11, 2025

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Given Average Rating of “Reduce” by Brokerages - Defense World

Dec 11, 2025
pulisher
Dec 10, 2025

Is Pliant Therapeutics Inc a good long term investmentHead and Shoulders Patterns & Superior Portfolio Investment - earlytimes.in

Dec 10, 2025
pulisher
Dec 08, 2025

Pliant Therapeutics to end employment of chief medical officer Dr. Éric Lefebvre - Investing.com Nigeria

Dec 08, 2025
pulisher
Dec 08, 2025

Pliant Therapeutics Announces Departure of Chief Medical Officer - TradingView

Dec 08, 2025
pulisher
Dec 08, 2025

Pliant Therapeutics Inc (PLRX) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews

Dec 08, 2025
pulisher
Dec 07, 2025

Pliant Therapeutics shares rise after early cancer drug data impresses - MSN

Dec 07, 2025
pulisher
Dec 06, 2025

Rishiroop Limited Recovery Likely Heres What Data ShowsVolume Analysis Techniques & Rapid Capital Portfolio - earlytimes.in

Dec 06, 2025
pulisher
Dec 06, 2025

Pliant Therapeutics (PLRX) Stock Analysis Report | Financials & Insights - Benzinga

Dec 06, 2025
pulisher
Dec 05, 2025

Pliant Therapeutics reports interim PLN-101095 Phase I trial data - Yahoo

Dec 05, 2025
pulisher
Dec 05, 2025

Pliant’s PLN-101095 shows promising results in cancer trial By Investing.com - Investing.com Nigeria

Dec 05, 2025
pulisher
Dec 05, 2025

Can Pliant Therapeutics Inc. stock sustain revenue growthJuly 2025 PreEarnings & Real-Time Volume Trigger Notifications - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

What hedge fund moves indicate for Pliant Therapeutics Inc. (9PT) stockJuly 2025 Review & Free Safe Capital Growth Stock Tips - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

Can Pliant Therapeutics Inc. (9PT) stock double in coming yearsJuly 2025 Snapshot & Risk Controlled Daily Trade Plans - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Why Pliant Therapeutics Inc. (9PT) stock could be top winnerBear Alert & Risk Controlled Daily Plans - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Why Is Pliant Therapeutics Stock Trading Lower TodayPliant Therapeutics (NASDAQ:PLRX) - Benzinga

Dec 04, 2025
pulisher
Dec 04, 2025

Pliant Therapeutics, Inc. (PLRX) -15.3% in Intraday Trading: Interim Data Announcement Fails to Support Price - Stocks Telegraph

Dec 04, 2025
pulisher
Dec 04, 2025

Pliant Therapeutics stock jumps on promising cancer drug trial results By Investing.com - Investing.com South Africa

Dec 04, 2025
pulisher
Dec 04, 2025

Pliant Therapeutics stock jumps on promising cancer drug trial results - Investing.com

Dec 04, 2025
pulisher
Dec 04, 2025

Pliant Therapeutics, Inc. Announces Interim Data from Pln-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors - marketscreener.com

Dec 04, 2025
pulisher
Dec 04, 2025

Pliant’s PLN-101095 shows promising results in cancer trial - Investing.com

Dec 04, 2025
pulisher
Dec 04, 2025

Pliant Therapeutics reveals promising early results for PLN-101095 - Traders Union

Dec 04, 2025
pulisher
Dec 04, 2025

Pliant Therapeutics announces interim data from PLN-101095 - marketscreener.com

Dec 04, 2025
pulisher
Dec 04, 2025

Pliant Therapeutics Announces Interim Data from PLN-101095 - GlobeNewswire

Dec 04, 2025
pulisher
Dec 04, 2025

Pliant Therapeutics Announces Interim Data from PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors - Sahm

Dec 04, 2025
pulisher
Dec 04, 2025

Is Pliant Therapeutics Inc. (9PT) stock considered safe havenTrade Volume Report & Community Consensus Stock Picks - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

Are Smart Investors Making the Right Decision? Pliant Therapeutics Inc (PLRX) - setenews.com

Dec 03, 2025
pulisher
Dec 03, 2025

Will Pliant Therapeutics Inc. (9PT) stock profit from fiscal stimulusMarket Risk Summary & Verified Swing Trading Watchlist - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Will Pliant Therapeutics Inc. stock attract more institutional investors - Newser

Dec 03, 2025
pulisher
Dec 01, 2025

Pliant Therapeutics to Participate in the Piper Sandler Healthcare Conference - Investing News Network

Dec 01, 2025
pulisher
Dec 01, 2025

Pliant Therapeutics (Nasdaq: PLRX) to host Dec. 4 fireside chat at Piper Sandler - Stock Titan

Dec 01, 2025
pulisher
Dec 01, 2025

Pliant Therapeutics Inc Stock Analysis and ForecastRSI Overbought/Oversold & Insights From Wall Street Professionals - earlytimes.in

Dec 01, 2025
pulisher
Nov 28, 2025

What drives Pliant Therapeutics Inc stock priceCapital Gains Strategies & Access Advanced Stock Screening Tools - earlytimes.in

Nov 28, 2025
pulisher
Nov 26, 2025

Wall Street analysts’ outlook for Pliant Therapeutics Inc (PLRX) - setenews.com

Nov 26, 2025
pulisher
Nov 25, 2025

Total debt per share of Pliant Therapeutics, Inc. – SWB:9PT - TradingView

Nov 25, 2025
pulisher
Nov 24, 2025

Pliant Therapeutics, Inc. (PLRX) Analyst insights, Price targets and Recommendations - Yahoo Finance UK

Nov 24, 2025
pulisher
Nov 21, 2025

Why Pliant Therapeutics Inc. (9PT) stock benefits from AI revolutionWeekly Loss Report & Accurate Intraday Trading Signals - newser.com

Nov 21, 2025
pulisher
Nov 19, 2025

Why Pliant Therapeutics Inc. stock is in analyst buy zone2025 Price Targets & Low Drawdown Investment Strategies - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How rising interest rates impact Pliant Therapeutics Inc. stockJuly 2025 Weekly Recap & Fast Entry High Yield Stock Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Pliant Therapeutics Inc (PLRX) expanding its growth trajectory ahead - Setenews

Nov 19, 2025
pulisher
Nov 19, 2025

Why global investors buy Pliant Therapeutics Inc. (9PT) stock2025 Geopolitical Influence & Free Real-Time Volume Trigger Notifications - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What high frequency data says about Pliant Therapeutics Inc.July 2025 News Drivers & Risk Adjusted Buy/Sell Alerts - newser.com

Nov 19, 2025
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
Kapitalisierung:     |  Volumen (24h):